153 related articles for article (PubMed ID: 29340062)
1. Correlation of psychooncological distress- screening and quality of life assessment in neurosurgical patients.
Hoffmann K; Kamp M; Steiger HJ; Sabel M; Rapp M
Oncotarget; 2017 Dec; 8(67):111396-111404. PubMed ID: 29340062
[TBL] [Abstract][Full Text] [Related]
2. Psychooncological distress in low-grade glioma patients-a monocentric study.
Ley A; Kamp M; von Sass C; Hänggi D; Sabel M; Rapp M
Acta Neurochir (Wien); 2022 Mar; 164(3):713-722. PubMed ID: 34159449
[TBL] [Abstract][Full Text] [Related]
3. Impact of Anticipated Awake Surgery on Psychooncological Distress in Brain Tumor Patients.
Staub-Bartelt F; Radtke O; Hänggi D; Sabel M; Rapp M
Front Oncol; 2021; 11():795247. PubMed ID: 35111678
[TBL] [Abstract][Full Text] [Related]
4. Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients.
Rapp M; Schipmann S; Hoffmann K; Wiewrodt R; Steiger HJ; Kamp M; Stummer W; Wiewrodt D; Sabel M
Oncotarget; 2018 Aug; 9(60):31650-31663. PubMed ID: 30167085
[TBL] [Abstract][Full Text] [Related]
5. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
[TBL] [Abstract][Full Text] [Related]
6. Screening for distress in patients with intracranial tumors during the first 6 months after diagnosis using self-reporting instruments and an expert rating scale (the basic documentation for psycho-oncology short form - PO-Bado SF).
Renovanz M; Tsakmaklis H; Soebianto S; Neppel I; Nadji-Ohl M; Beutel M; Werner A; Ringel F; Hickmann AK
Oncotarget; 2018 Jul; 9(57):31133-31145. PubMed ID: 30123432
[TBL] [Abstract][Full Text] [Related]
7. Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways.
Schaeffeler N; Pfeiffer K; Ringwald J; Brucker S; Wallwiener M; Zipfel S; Teufel M
Psychooncology; 2015 Dec; 24(12):1784-91. PubMed ID: 26042392
[TBL] [Abstract][Full Text] [Related]
8. Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.
Hickmann AK; Hechtner M; Nadji-Ohl M; Janko M; Reuter AK; Kohlmann K; Haug M; Grüninger S; Deininger M; Ganslandt O; König J; Wirtz CR; Coburger J; Renovanz M
J Neurooncol; 2017 Jan; 131(1):135-151. PubMed ID: 27638638
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.
Bunevičius A; Tamašauskas Š; Tamašauskas A; Deltuva V
Medicina (Kaunas); 2012; 48(11):588-94. PubMed ID: 23455894
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
11. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy.
Papadopoulou A; Govina O; Tsatsou I; Mantzorou M; Mantoudi A; Tsiou C; Adamakidou T
Med Pharm Rep; 2022 Oct; 95(4):418-429. PubMed ID: 36506609
[TBL] [Abstract][Full Text] [Related]
12. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
13. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
14. Depression, anxiety, and health related quality of life among colorectal cancer survivors.
Aminisani N; Nikbakht H; Asghari Jafarabadi M; Shamshirgaran SM
J Gastrointest Oncol; 2017 Feb; 8(1):81-88. PubMed ID: 28280612
[TBL] [Abstract][Full Text] [Related]
15. Assessment Practice of Patient-Centered Outcomes in Surgical Neuro-Oncology: Survey-Based Recommendations for Clinical Routine.
Weiss Lucas C; Renovanz M; Jost J; Sabel M; Wiewrodt D; Rapp M
Front Oncol; 2021; 11():702017. PubMed ID: 34458144
[TBL] [Abstract][Full Text] [Related]
16. Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
Oort Q; Zwinkels H; Koekkoek JAF; Vos MJ; Reijneveld JC; Taphoorn MJB; Dirven L
Psychooncology; 2022 Jun; 31(6):995-1002. PubMed ID: 35083812
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
18. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
19. Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients.
Meraner V; Giesinger J; Kemmler G; Taucher S; Hubalek M; Weber B; Rumpold G; Sperner-Unterweger B; Holzner B
Psychooncology; 2009 Sep; 18(9):974-83. PubMed ID: 19142844
[TBL] [Abstract][Full Text] [Related]
20. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
